This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: H. Lundbeck A/s. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Baek: Innovator in Orexin Receptor Agonists
Introduction: Michael Baek is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the orexin receptor system. His work is crucial for advancing treatments related to sleep disorders and other health issues.
Latest Patents: Michael Baek holds a patent for "Spiromacrocyclic orexin 2 receptor agonists." This invention relates to novel spiro-macrocyclic compounds of general formula (I), which function as Orexin 2 receptor agonists. The patent highlights the potential of these compounds in therapeutic applications.
Career Highlights: Michael Baek is associated with H. Lundbeck A/S, a prominent pharmaceutical company known for its focus on brain diseases. His role at the company allows him to contribute to innovative research and development in the field of neuroscience.
Collaborations: One of his notable collaborators is Wanwan Yu. Together, they work on advancing the understanding and application of orexin receptor agonists.
Conclusion: Michael Baek's contributions to the field of pharmacology, particularly through his patent on orexin receptor agonists, showcase his innovative spirit and dedication to improving health outcomes. His work at H. Lundbeck A/S further emphasizes the importance of collaboration in scientific advancements.